Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Mar 22;10(4):489.
doi: 10.3390/vaccines10040489.

Pivotal Shigella Vaccine Efficacy Trials-Study Design Considerations from a Shigella Vaccine Trial Design Working Group

Patricia B Pavlinac  1 , Elizabeth T Rogawski McQuade  2 , James A Platts-Mills  3 , Karen L Kotloff  4 , Carolyn Deal  5 , Birgitte K Giersing  6 , Richard A Isbrucker  6 , Gagandeep Kang  7 , Lyou-Fu Ma  8 , Calman A MacLennan  8 , Peter Patriarca  9 , Duncan Steele  8 , Kirsten S Vannice  8
Affiliations

Pivotal Shigella Vaccine Efficacy Trials-Study Design Considerations from a Shigella Vaccine Trial Design Working Group

Patricia B Pavlinac et al. Vaccines (Basel). .

Abstract

Vaccine candidates for Shigella are approaching phase 3 clinical trials in the target population of young children living in low- and middle-income countries. Key study design decisions will need to be made to maximize the success of such trials and minimize the time to licensure and implementation. We convened an ad hoc working group to identify the key aspects of trial design that would meet the regulatory requirements to achieve the desired indication of prevention of moderate or severe shigellosis due to strains included in the vaccine. The proposed primary endpoint of pivotal Shigella vaccine trials is the efficacy of the vaccine against the first episode of acute moderate or severe diarrhea caused by the Shigella strains contained within the vaccine. Moderate or severe shigellosis could be defined by a modified Vesikari score with dysentery and molecular detection of vaccine-preventable Shigella strains. This report summarizes the rationale and current data behind these considerations, which will evolve as new data become available and after further review and consultation by global regulators and policymakers.

Keywords: Shigella; low and middle-income countries; pediatrics; vaccine trial design.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

References

    1. Liu J., Platts-Mills J.A., Juma J., Kabir F., Nkeze J., Okoi C., Operario D.J., Uddin J., Ahmed S., Alonso P.L., et al. Use of quantitative molecular diagnostic methods to identify causes of diarrhoea in children: A reanalysis of the GEMS case-control study. Lancet. 2016;388:1291–1301. doi: 10.1016/S0140-6736(16)31529-X. - DOI - PMC - PubMed
    1. Platts-Mills J.A., Liu J., Rogawski E.T., Kabir F., Lertsethtakarn P., Siguas M., Khan S.S., Praharaj I., Murei A., Nshama R., et al. Use of quantitative molecular diagnostic methods to assess the aetiology, burden, and clinical characteristics of diarrhoea in children in low-resource settings: A reanalysis of the MAL-ED cohort study. Lancet Glob. Health. 2018;6:e1309–e1318. doi: 10.1016/S2214-109X(18)30349-8. - DOI - PMC - PubMed
    1. Pholwat S., Liu J., Taniuchi M., Haque R., Alam M.M., Faruque A.S.G., Ferdous T., Ara R., Platts-Mills J.A., Houpt E.R. Use of Molecular Methods To Detect Shigella and Infer Phenotypic Resistance in a Shigella Treatment Study. J. Clin. Microbiol. 2022;60:e0177421. doi: 10.1128/JCM.01774-21. - DOI - PMC - PubMed
    1. Schnee A.E., Haque R., Taniuchi M., Uddin M.J., Alam M.M., Liu J., Rogawski E.T., Kirkpatrick B., Houpt E.R., Petri W.A., Jr., et al. Identification of Etiology-Specific Diarrhea Associated With Linear Growth Faltering in Bangladeshi Infants. Am. J. Epidemiol. 2018;187:2210–2218. doi: 10.1093/aje/kwy106. - DOI - PMC - PubMed
    1. Platts-Mills J.A., Houpt E.R., Liu J., Zhang J., Guindo O., Sayinzoga-Makombe N., McMurry T.L., Elwood S., Langendorf C., Grais R.F., et al. Etiology and Incidence of Moderate-to-Severe Diarrhea in Young Children in Niger. J. Pediatric Infect. Dis. Soc. 2021;10:1062–1070. doi: 10.1093/jpids/piab080. - DOI - PMC - PubMed

LinkOut - more resources